-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Moderna, Zscaler And This Biotechnology Stock Insiders Are Selling
Moderna, Zscaler And This Biotechnology Stock Insiders Are Selling
US crude oil futures traded higher this morning on Monday. Investors, meanwhile, focused on some notable insider trades.
When insiders sell shares, it indicates their concern in the company's prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.
Below is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform.
Moderna
- The Trade: Moderna, Inc. (NASDAQ:MRNA) Director Noubar B. Afeyan sold a total of 10,000 shares at an average price of $123.58. The insider received around $1.24 million from selling those shares.
- What's Happening: Moderna refused to hand over to China the core intellectual property related to the development of its famed COVID-19 vaccine.
- What Moderna Does: Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018.
Also check this: Wells Fargo To Surge Around 20%? Here Are 5 Other Price Target Changes For Monday
Zscaler
- The Trade: Zscaler, Inc. (NASDAQ:ZS) Chief Operating Officer Dali Rajic sold a total of 20,000 shares at an average price of $168.00. The insider received around $3.36 million as a result of the transaction.
- What's Happening: Zscaler announced it has completed its acquisition of ShiftRight.
- What Zscaler Does: Zscaler is a security-as-a-service firm that offers its customers cloud-delivered solutions for protecting user devices and data.
Have a look at our premarket coverage here .
AlloVir
- The Trade: AlloVir, Inc. (NASDAQ:ALVR) Director David Hallal sold a total of 400,000 shares at an average price of $7.35. The insider received around $2.94 million from selling those shares.
- What's Happening: The company's shares have dipped around 42% since the start of the year.
- What AlloVir Does: AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases.
US crude oil futures traded higher this morning on Monday. Investors, meanwhile, focused on some notable insider trades.
美国原油期货周一早盘走高。与此同时,投资者关注的是一些值得注意的内幕交易。
When insiders sell shares, it indicates their concern in the company's prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.
当内部人士出售股票时,这表明他们对公司前景的担忧,或者他们认为股票定价过高。无论哪种方式,这都标志着做空该股的机会。内幕交易不应被视为做出投资或交易决定的唯一指标。充其量,它可以让抛售决定更有说服力。
Below is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform.
以下是最近一些值得注意的内幕交易。欲了解更多信息,请查看Benzinga的内幕交易站台。
Moderna
Moderna
- The Trade: Moderna, Inc. (NASDAQ:MRNA) Director Noubar B. Afeyan sold a total of 10,000 shares at an average price of $123.58. The insider received around $1.24 million from selling those shares.
- What's Happening: Moderna refused to hand over to China the core intellectual property related to the development of its famed COVID-19 vaccine.
- What Moderna Does: Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018.
- 行业:Moderna公司:董事努巴尔·阿菲扬共售出10,000股均价为123.58美元。这位内部人士从出售这些股票中获得了约124万美元。
- 正在发生的事情:Moderna拒绝向中国移交与其著名的新冠肺炎疫苗开发相关的核心知识产权。
- Moderna的用途:Moderna是一家商业阶段的生物技术公司,成立于2010年,于2018年12月进行首次公开募股。
Also check this: Wells Fargo To Surge Around 20%? Here Are 5 Other Price Target Changes For Monday
还要检查一下:富国银行的股价将飙升20%左右?以下是周一的其他5个目标价变化
Zscaler
Zscaler
- The Trade: Zscaler, Inc. (NASDAQ:ZS) Chief Operating Officer Dali Rajic sold a total of 20,000 shares at an average price of $168.00. The insider received around $3.36 million as a result of the transaction.
- What's Happening: Zscaler announced it has completed its acquisition of ShiftRight.
- What Zscaler Does: Zscaler is a security-as-a-service firm that offers its customers cloud-delivered solutions for protecting user devices and data.
- 行业: Zscaler,Inc.(纳斯达克:ZS)首席运营官达利·拉吉奇共出售20,000股均价为168.00美元。这位内部人士通过这笔交易获得了约336万美元。
- 正在发生的事情:Zscaler宣布已经完成了对ShiftRight的收购。
- Zscaler做了什么:Zscaler是一家安全即服务公司,为客户提供云交付的解决方案,以保护用户设备和数据。
Have a look at our premarket coverage here .
在这里看看我们的售前报道。
AlloVir
AllVir
- The Trade: AlloVir, Inc. (NASDAQ:ALVR) Director David Hallal sold a total of 400,000 shares at an average price of $7.35. The insider received around $2.94 million from selling those shares.
- What's Happening: The company's shares have dipped around 42% since the start of the year.
- What AlloVir Does: AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases.
- 行业: 阿洛维尔,Inc.(纳斯达克:ALVR)董事大卫·哈拉尔总共出售了400,000股平均价格为7.35美元。这位内部人士从出售这些股票中获得了约294万美元。
- 正在发生的事情:自今年年初以来,该公司的股价已经下跌了约42%。
- AlloVir的作用:阿洛维尔公司是一家临床晚期细胞治疗公司。它正在开发同种异体T细胞疗法,以治疗和预防毁灭性的病毒疾病。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧